A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: dopaminergic function and personality traits)

Drug Chem Toxicol. 2009;32(4):301-6. doi: 10.1080/01480540903203976.

Abstract

The nicotine metabolism of CYP2A6 (CYP2A6*1A,*1B, and *1C), and the cholecystokinin (CCK; which modulates the release of dopamine) and CCK-A receptor gene and personality traits for NEO-FFI, was investigated for the mechanism for elucidation of the smoking behavior in Japanese populations. The frequency of the CYP2A6*4C allele, which is a whole deleted allele of the human CYP2A6 gene, was higher, whereas that of CYP2A6*1A/*1B heterozygotes with higher nicotine metabolism activity was lower in nonsmokers than in smokers. There was also a significant difference between the current smoking and nonsmoking groups in the allele frequency of the CCK -45C/T polymorphism. It was also shown that the Openness (O) factor for smokers was significantly higher than that of nonsmokers; however, there were no significant differences in the Neuroticism (N), Extraversion (E), Agreeable (A), and Conscientiousness (C) scores among smokers than nonsmokers. It was suggested that the CYP2A6*4C allele may prevent the carrier from smoking, and being a CYP2A6*1A/*1B heterozygote and the CCK T allele may be risk factors for developing smoking behavior. Also, it is possible that persons with a low score in Openness may be refraining from smoking because they have a general negative impression toward smoking.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alleles
  • Asian People / genetics
  • Dopamine / metabolism
  • Gene Deletion*
  • Gene Frequency*
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genotype
  • Health Knowledge, Attitudes, Practice
  • Heterozygote
  • Humans
  • Insomnia, Fatal Familial / epidemiology
  • Insomnia, Fatal Familial / genetics
  • Polymorphism, Genetic*
  • Receptor, Cholecystokinin A / genetics*
  • Receptor, Cholecystokinin A / metabolism
  • Risk Factors
  • Smoking / genetics*
  • Smoking / metabolism
  • Tobacco Use Disorder / genetics*

Substances

  • Receptor, Cholecystokinin A
  • Dopamine